Abstract
Introduction
In the cell biology, the term autophagy defines the catabolic process regulating the degradation of a cell's own components through the lysosomal machinery [1, 2] . Autophagy is a genetically regulated process that plays an important homeostatic role in
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cells, preserving the balance between the synthesis, degradation and subsequent recycling of cellular components [3]. The term 'autophagy', derived from the Greek and meaning 'eating of self', was first coined by Christian de Duve over 40 years ago, and was largely based on the observed degradation of mitochondria and other intracellular structures within lysosomes
Autophagy is an evolutionarily conserved and strictly regulated lysosomal pathway that degrades cytoplasmic material and organelles. It is activated during stress conditions such as metabolic stress, amino acid starvation, unfolded protein response or viral infection [8, 9] . It has been suggested that autophagy, limiting necrosis and inflammation, inducing cell cycle arrest and preventing genome instability, could prevent tumorigenesis [10] . Autophagy has also recently been shown to be required for key aspects of the senescent cell phenotype [11] , which is known to be anti-tumorigenic. However, as a cell survival mechanism, other authors have argued that autophagy may promote intrinsic drug resistance and tumour cell adaptation to dysmetabolic stress [12] .
Although the importance of autophagy is well recognized in mammalian systems, many of the mechanistic breakthroughs in delineating how autophagy is regulated and executed at the molecular level have been made in yeast (Saccharomyces cerevisiae) [13] . Currently, 32 different autophagy-related genes (Atg) have been identified by genetic screening in yeast and, significantly, many of these genes are conserved in slime mould, plants, worms, flies and mammals, emphasizing the importance of the autophagic process in responses to starvation across phylogeny [5] . There are three defined types of autophagy: macro-autophagy, micro-autophagy and chaperone-mediated autophagy, all of which promote proteolytic degradation of cytosolic components at the lysosome (Fig. 1) . A decreased or defective autophagy is pathogenetic.
Macro-autophagy delivers cytoplasmic cargos to the lysosome through the intermediary of a double membrane bound vesicle, referred as to an autophagosome, which fuses with the lysosome to form an autolysosome. In micro-autophagy, by contrast, cytosolic components are directly taken up by the lysosome itself through invagination of the lysosomal membrane. Both macroand micro-autophagy are able to engulf large structures through both selective and non-selective mechanisms. In chaperone-medi-
[6], [50] [51] [52] , [55] , [59] , [85] AID In systemic lupus erythematosus, scleroderma, rheumatoid arthritis, primary biliary cirrhosis, autoimmune thyroid disease, Sjogren's syndrome and multiple sclerosis.
Involved in the promotion of MHC class II presentation and breakdown of tolerance. [73] , [75] [76] , [81] Cardiovascular diseases
In several vascular and heart diseases, including diabetes, thrombosis, hypertension, coronary heart disease, metabolic syndrome, cardiac fibrosis.
Autophagy confers cytoprotection under metabolic and ischemic stress.
[ [85] [86] [87] , [89] , [91] , [95] [96] , [98] , [102] , [135] Cancer Autophagy and cancer [49] . [50] . This implies fundamental differences between men and women in the underlying pathophysiology, which in turn has implications for responsiveness to treatments [51, 52] [55, 56] and autophagic compartments were identified as a major reservoir of intracellular A␤ in the brain of Alzheimer patients and mouse models [57, 58] . A recent study challenges the idea that autophagy contributes to the pathogenesis of Alzheimer's disease via changes in Beclin-1 expression [58] . 3 protein) , the autophagosome-specific form of LC3, suggesting that autophagy is induced [59] . Further works also claim that increased autophagy may be harmful for neurons in patients with Niemann-Pick disease [60, 61] . [62] [63] [64] [66] . [82] .
Neurodegenerative diseases Gender differences in neurodegenerative diseases

Role of autophagy in neurodegenerative diseases
A further example of the involvement of autophagy in neurodegeneration could be considered the Niemann-Pick neurodegenerative disease. This is lipid storage disorder characterized by a disruption of sphingolipid and cholesterol trafficking caused by mutations in either of two genes, npc1 and npc2 (Niemann-Pick C genes). The disease produces cognitive impairment, ataxia and death, often in childhood. Cells deficient in npc genes show increased expression of Beclin-1 and LC3-II (light chain-
Gender differences and hormones
Without doubt, oestrogen has been pinpointed as a critical protective factor in females that gives them the advantage in diseases prevalent in men, whereas its rapid decline after menopause may forfeit this advantage. In theory, oestrogen holds great clinical potential for central nervous system disorders because of its proven neuroprotective and neuroactivating properties
Autoimmune and inflammatory diseases Gender differences in autoimmune diseases
Cardiovascular diseases Gender disparity in cardiovascular diseases
Gender in heart and vascular diseases has widely been investigated since many years [83, 84] (Table 1) [84] . Briefly, it was recognized that women typically develop heart disease later than men and with a better prognosis [85] . From animal studies we learned that there are clear differences in the degree and/or the type of pathological hypertrophy in response to cardiac insults between males and females [86] . Male spontaneously hypertensive rats developed more cardiac hypertrophy and left ventricular dysfunction than females. Subsequent heart failure also occurred earlier in males than females [87] . Similar findings were reported in response to pressure overload (aortic-banding) [88] . Comparable gender differences have also been reported in human beings, though the data are generally less conclusive owing to confounding factors (e.g. treatments, lifestyle), the relatively small sample sizes and the limited number of studies in patients with pure pressure overload (i.e. in the absence of coronary heart disease) [84, 89] .
. In particular, the Framingham study investigated into the evolution of cardiovascular disease suggesting the presence of a gender difference in the pathogenetic and progression determinants detectable in men and women. For instance, women were found to outlive men and to experience fewer atherosclerotic cardiovascular events, with an incidence lagging behind that in men by 10 to 20 years
The molecular mechanisms underlying these gender dimorphisms are complex and are still not well understood [90, 91] [92, 93] . The sex steroid hormones (oestrogen, progesterone and testosterone) and their respective receptors are thus thought to mediate, at least in part, gender differences in the heart [85, 91] .
. In general, pre-menopausal women tend to be protected against cardiovascular disease compared with age-matched men, but this protection is abolished following menopause. Thus, it has been suggested that oestrogen has protective properties and activation of signalling cascades downstream of oestrogen may explain gender-related differences in the heart
Autophagy and heart diseases
Although altered autophagy has been observed in various heart diseases, including cardiac hypertrophy and heart failure, it remains unclear whether autophagy plays a beneficial or detrimental role in these diseases [94, 95] . In the heart, autophagy is important for the turnover of organelles at low basal levels under normal conditions and it is up-regulated in response to stresses such as ischemia/reperfusion and in cardiovascular diseases such as heart failure ( Table 1) . As mentioned earlier, tissue-specific deletion of ATG5 in the heart causes cardiac hypertrophy and contractile dysfunction [96] [105, 106] . However, several further actors seem to play a role in autophagy pathway in heart disease. For instance, it has been shown that oxidative stress, ER stress and changes in the ubiquitin-proteasomal system are intimately involved in the regulation of autophagy in the heart, removing damaged organelles, such as mitochondria, and maintaining ER homeostasis [107, 108] . Conversely, pro-apoptotic factors can be released from the damaged mitochondria, leading to apoptotic cell death [109] . In particular, in the absence of autophagy, the accumulation of polyubiquitinated proteins may be responsible for increased ER stress, and determine cell death by apoptosis [96] . Hence, the balance between autophagy and apoptosis appears as a critical point. In fact, many of the autophagosomes can contain mitochondria in the adult rat myocardium under severe stress such as ischemia/reperfusion suggesting that excessive autophagic activity induced by severe stimuli can destroy a large fraction of the cytosol and organelles and release apoptosis-related factors, leading to cell death [96] . Indeed, characteristics of autophagy, apoptosis and necrosis can also be simultaneously observed in failing hearts [102] .
Several signalling pathways that are induced by common cellular stressors regulate both autophagy and apoptosis. ROS not only trigger apoptosis but are also essential for autophagy and specifically regulate ATG4 activity [110, 111] . ROS produces damaged proteins and organelles and lipid peroxidation in mitochondria, thereby promoting autophagy [112, 113] . However, ROS may also stimulate autophagosome formation through direct oxidative modifications of the autophagic machinery [113] . [116] . During cardiac reperfusion phase there is an increased expression of Beclin-1/ATG6 in the heart [117] . Recently [119] . A last point concerns type 2 diabetes. Type 2 diabetes has to be considered as a gender-associated disease: sex differences play in fact a key role in the onset as well as in the progression of the disease and a higher mortality for cardiovascular diseases is detected in diabetic women with respect to men [120] . Altogether these studies validate the hypothesis of a connection between gender differences and cardiovascular diseases. However, further research to point out appropriate animal models for gender-biased studies on this issue appears as mandatory [121] .
Members of the beclin1 and Bcl-2 family could serve as a point of cross-talk between the autophagic and apoptotic pathways. Beclin-1, primarily localized at ER [114], was originally identified as a Bcl-2-interacting protein [115]. Bcl-2 inhibits Beclin-1/dependent autophagy in yeast and mammalian cells and cardiac Bcl-2 transgenic expression also inhibits autophagy in murine heart cells
Autophagy and cell sex differences
The first direct evidence establishing the relationship between autophagy and morphological changes in androgen-dependent organs is shown by Coto-Montes et al. [122] . The variations in androgen levels have been shown to be the most important factor for the development of autophagy, and this information could be very useful for gaining knowledge in the field. However, the literature on this argument, i.e. at cellular level, is still limited. It has been suggested that 17␤-estradiol could influence autophagy [123] , whereas Beclin-1 seems able to down-regulate oestrogenic signalling and growth response, suggesting an important interaction between the two systems [124] . Other studies have shown that endocrine regulation could influence autophagy [125] . One example of hormone-dependent autophagic regulation is shown in hepatocytes. In fact, under low concentrations of amino acids, insulin stimulates mTOR signalling and simultaneously inhibits autophagy, whereas glucagon has the opposite effects, i.e. it inhibits signalling and stimulates autophagy (Fig. 3) [126] . Some animal models also provided some useful novel insight in this respect. One [127] . [128] . In particular, insulin hormone seems involved in autophagic pathway of a wide range of human diseases [129] [133] . [134] . Because activation of STAT3 has been associated with autophagic processes [135] and it has been suggested that JNK phosphorylates Bcl-2 triggering its release from Beclin 1 in response to various stimuli [136] (Fig. 4) . However, importantly, the same authors did not observe similar findings in a different cell type, i.e. fibroblasts. They thus suggest that autophagic response could be both sex-and tissue dependent [85] . 
Some further insights at cellular level derived from the analyses of mechanisms instructing the autophagic pathways. A paradigmatic example is represented by the insulin signalling. In fact, autophagy is regulated by several signal-transduction pathways. The most important is the insulin-growth factor-amino acid-mTOR pathway: its inhibition activates autophagy in all eukaryotes
Concluding remarks
